BrainAurora Medical Technology Limited (HKG:6681)
Hong Kong · Delayed Price · Currency is HKD 5.79
-0.58 (-9.11%)
At close: Jan 23, 2026
HKG:6681 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -210.32 | -198.28 | -359.08 | -502.45 | -697.84 |
Depreciation & Amortization | 26.27 | 26.27 | 21 | 12.36 | 1.55 |
Other Amortization | 0.88 | 0.88 | 0.27 | 0.07 | 0.08 |
Loss (Gain) From Sale of Assets | -0 | -0 | 0.06 | 0.13 | -0.01 |
Loss (Gain) From Sale of Investments | -0.01 | -0.01 | -2.67 | -3.24 | - |
Stock-Based Compensation | 66.77 | 66.77 | 44.87 | - | 19.37 |
Provision & Write-off of Bad Debts | 11.48 | 11.48 | 0.85 | 0.05 | 0.01 |
Other Operating Activities | -36.86 | -14.27 | 183.54 | 401.2 | 628.83 |
Change in Accounts Receivable | -64.45 | -64.45 | -48.01 | -11.79 | -6.01 |
Change in Accounts Payable | 12.33 | 12.33 | 23.44 | 2.07 | 4.85 |
Change in Unearned Revenue | 9.68 | 9.68 | 2.71 | 0.72 | 0.39 |
Change in Other Net Operating Assets | 3.56 | 3.56 | -3.84 | 0.21 | -0.44 |
Operating Cash Flow | -180.67 | -146.04 | -136.87 | -100.68 | -49.21 |
Capital Expenditures | -14.98 | -17.33 | -15.97 | -16.4 | -10.8 |
Sale of Property, Plant & Equipment | 0.05 | 0.07 | 0.25 | 0.02 | 0.01 |
Sale (Purchase) of Intangibles | -7.77 | -0.37 | -2.05 | -2.66 | -0.02 |
Investment in Securities | -107.99 | 0.01 | 333.46 | -327.55 | - |
Other Investing Activities | 23.4 | 144.91 | -212.64 | 2.63 | -1.17 |
Investing Cash Flow | -130.18 | 123.38 | 102.55 | -334.46 | -21.48 |
Short-Term Debt Issued | - | 335.04 | 15 | 6.96 | - |
Long-Term Debt Issued | - | - | - | 50 | 350 |
Total Debt Issued | 471.92 | 335.04 | 15 | 56.96 | 350 |
Short-Term Debt Repaid | - | -15 | -2.36 | - | -4.09 |
Long-Term Debt Repaid | - | -8.26 | -7.95 | -6.25 | -0.81 |
Total Debt Repaid | -124.25 | -23.26 | -10.31 | -6.25 | -4.89 |
Net Debt Issued (Repaid) | 347.67 | 311.78 | 4.69 | 50.71 | 345.11 |
Issuance of Common Stock | 218.2 | - | 153.12 | 89.5 | 63.7 |
Other Financing Activities | -21.79 | -2.98 | -94.28 | -0.57 | -15.19 |
Financing Cash Flow | 544.08 | 308.81 | 63.53 | 139.65 | 393.61 |
Foreign Exchange Rate Adjustments | -1.22 | 0.16 | 0.12 | 0.01 | - |
Net Cash Flow | 232.02 | 286.31 | 29.33 | -295.49 | 322.93 |
Free Cash Flow | -195.65 | -163.37 | -152.84 | -117.08 | -60.01 |
Free Cash Flow Margin | -114.77% | -133.57% | -227.44% | -1036.94% | -2610.05% |
Free Cash Flow Per Share | -0.19 | -0.16 | -0.26 | -0.42 | -0.40 |
Cash Interest Paid | 1.53 | 1.02 | 0.63 | 0.57 | 0.19 |
Cash Income Tax Paid | 0.05 | 0.05 | - | - | - |
Levered Free Cash Flow | -117.56 | 8.4 | -252.93 | -82.34 | - |
Unlevered Free Cash Flow | -103.12 | 22.17 | -240.29 | -70.32 | - |
Change in Working Capital | -38.88 | -38.88 | -25.71 | -8.8 | -1.2 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.